Replies to post #179672 on Biotech Values

[DewDiligence]

A MON-SYT merger would’ve faced a plethora of antitrust issues.

SYT closed +7% today (a very large move for this stock), despite the MON deal being called off. Investors evidently expect MON to re-emerge or another suitor—such as DD, DOW, BASF, or Bayer—to show up.